Male Breast Carcinoma Active Not Recruiting Phase 3 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00770809Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryTreatment